Permanens Capital L.P. United Therapeutics Corp Transaction History

Permanens Capital L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$92.74 - $125.82 $0 - $0	0 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $0 - $0	0 New	0 $0
Q4 2019 Feb 13, 2020	SELL	$78.31 - $95.34 $113,549 - $138,243	-1,450 Closed	0 $0
Q3 2019 Nov 06, 2019	SELL	$74.85 - $85.99 $351,795 - $404,153	-4,700 Reduced 76.42%	1,450 $116,000
Q2 2019 Aug 09, 2019	BUY	$76.06 - $120.81 $11,409 - $18,121	150 Added 2.5%	6,150 $480,000

Q1 2019 May 13, 2019	BUY	$107.15 - $126.84 $642,900 - $761,040	6,000 New	6,000 $704,000

562

43.1M

501K

529K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $15B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Permanens Capital L.P., based on Form 13F filings with the SEC.

Stay updated on Permanens Capital L.P. with notifications on news.